Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

11289	Companies
250843	Keywords
179648	Articles
136680	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 04/29/2024 at 14:39, 2 years 6 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces the implementation of a dedicated partnership strategy in obesity, aiming to collaborate with global pharmaceutical companies for drug development and commercialization. CEO Stanislas Veillet emphasizes the importance of addressing the obesity medical challenge through partnerships

Biophytis Drug Development Obesity Partnership Strategy Pharmaceutical Companies
BRIEF

published on 04/29/2024 at 07:05, 2 years 6 months ago

Biophytis Advances Partnership Strategy in Obesity Sector

Biophytis Obesity Treatment Healthcare Innovation Pharmaceutical Partnerships BIO101
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 2 years 6 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 2 years 6 months ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 2 years 6 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 2 years 6 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 2 years 6 months ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years 6 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt (ADR) program, with effective date expected to be April 23, 2024

Biophytis Stock Market American Depositary Receipt ADR Program Ratio Change
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years 6 months ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt program, affecting ADS to Shares ratio. No new shares issued, trading price may increase. Details provided in the press release

Biophytis Shares Ads American Depositary Receipt Ratio Change
BRIEF

published on 04/18/2024 at 07:05, 2 years 6 months ago

Biophytis Announces New Scientific Advisory Board for Phase 2 Obesity Study

Biophytis Scientific Advisory Board BIO101 Obesity OBA Clinical Study

Accesswire

Published on 11/06/2026 at 01:20, 33 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 1 hour ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 8 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:20, 2 hours 33 minutes ago

Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/05/2026 at 22:05, 3 hours 48 minutes ago

Innodata Reports Record Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/06/2026 at 00:05, 1 hour 48 minutes ago

RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 3 hours 48 minutes ago

Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 15 minutes ago

freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 16 minutes ago

EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 7 minutes ago

Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets

Les Echos

Published on 11/05/2026 at 18:21, 7 hours 31 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:50, 8 hours 3 minutes ago

NRJ GROUP - Financial information Q3 2026
Published on 11/05/2026 at 17:45, 8 hours 8 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 8 hours 24 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 15 hours 37 minutes ago

Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%

View all LES ECHOS COMFI WIRE